Vincent Couloigner

Vincent Couloigner

Auto-generated profile, based on publicly available information

Vincent Couloigner

Université Paris Cité, UFR de Médecine Paris France

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2023 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
SPSanjay R. Parikh
Sanjay R. Parikh
ABAn Boudewyns
An Boudewyns
NFNorman R. Friedman
Norman R. Friedman
SSSeth Roslow Schwartz
Seth Roslow Schwartz
CBCristina M. Baldassari
Cristina M. Baldassari
DLDerek Lam
Derek Lam

15 May 2019 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
Luca PioLuca Pio
Luca Pio
PVPatricio Varela
Patricio Varela
MEMartin J. Eliott
Martin J. Eliott
VCVincent Couloigner
Vincent Couloigner
GBGabriela Guillén Burrieza
Gabriela Guillén Burrieza
MTMichele Torre
Michele Torre

23 January 2023 in Annals of Surgery
Verified
Journal Article
Closed access
NVNicolas Vinit
Nicolas Vinit
FVFabrizio Vatta
Fabrizio Vatta
ABAline Broch
Aline Broch
MHMary Hidalgo
Mary Hidalgo
JKJules Kohaut
Jules Kohaut
TBThomas Blanc
Thomas Blanc
Objective: To report one-year morbidity of robotic-assisted laparoscopic surgery (RALS) in a dedicated, multidisciplinary, pediatric robotic surgery program. Summary Background Data. RALS in pediatric surgery is expanding, but data on morbidity in children is limited. Methods: All children who underwent RALS (Da Vinci Xi, Intuitive Surgical, USA) were prospectively included (October 2016 to May 2020; follow-up ≥1 year). Analyzed data: patient characteristics, surgical indication/procedure, intraoperative adverse events (ClassIntra classification), blood transfusion, hospital stay, postoperative complications (Clavien-Dindo). Results: Three hundred consecutive surgeries were included: urology/gynecology (n=105), digestive surgery (n=83), oncology (n=66), ENT surgery (n=28), thoracic surgery (n=18). Median age and weight at surgery were 9.5 [interquartile range (IQR)=8.8] years and 31 [IQR=29.3] kg, respectively. Over one year, 65 (22%) children presented with ≥1 complication, with Clavien-Dindo ≥III in 14/300 (5%) children at ≤30 days, 7/300 (2%) at 30-90 days, and 12/300 (4%) at >90 days. Perioperative transfusion was necessary in 15 (5%) children, mostly oncological (n=8). Eight (3%) robotic malfunctions were noted, one leading to conversion (laparotomy). Overall conversion rate was 4%. ASA ≥3, weight ≤15 kg, and surgical oncology did not significantly increase the conversion rate, complications, or intraoperative adverse events (ClassIntra ≥2). ASA score was significantly higher in children with complications (Clavien-Dindo ≥III) than without (p=0.01). Median hospital stay was 2 [IQR=3] days. Three children died after a median follow-up of 20 [IQR=16] months. Conclusions: RALS is safe, even in the most vulnerable children with a wide scope of indications, age, and weight. Robot-specific complications or malfunctions are scarce.

19 January 2017 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
GBGrégoire Boulouis
Grégoire Boulouis
VDV. Dangouloff-Ros
V. Dangouloff-Ros
OBO. Boccara
O. Boccara
NGN. Garabedian
N. Garabedian
VSV. Soupre
V. Soupre
FBF. Brunelle
F. Brunelle
BACKGROUND AND PURPOSE: Differentiating major subtypes of cervicofacial vascular lesions is crucial for appropriate management. The aim of our study was to evaluate the performance of an MR imaging arterial spin-labeling perfusion sequence in discriminating pediatric cervicofacial soft-tissue vascular anomalies. MATERIALS AND METHODS: We conducted a retrospective analysis of data from a prospectively maintained registry including pediatric patients at a tertiary pediatric center between January 2012 and January 2014. We included pediatric patients with a final diagnosis of soft-tissue vascular anomalies and an MR imaging, including an arterial spin-labeling sequence at presentation. We performed an analysis of lesion perfusion, blinded to clinical data, by using concurrent spiral 3D pseudocontinuous arterial spin-labeling (1.5T magnet; spiral matrix, 512 × 8 mm; postlabeling delay, 1025 ms). Lesional flow was recorded with calibrated intralesional ROIs. Perfusion characteristics were compared among lesion subtypes with the Mood Median test. RESULTS: Among 840 patients screened, 46 matched the inclusion criteria and were included (median age, 1.45 years; interquartile range, 0.4–5.1 years; 27 females). Hemangiomas, including infantile hemangiomas (n = 18 patients) and noninvoluting (n = 2) and rapidly involuting (n = 1) congenital types, demonstrated marked hyperperfusion (median flow, 436 mL/min/100 g; interquartile range, 212.5–603 mL/min/100 g), significantly higher than that of lymphatic malformations (median, 22.5 mL/min/100 g; interquartile range, 16–60 mL/min/100 g; P < .001) or venous malformations (median, 25 mL/min/100 g; interquartile range, 15–66.5 mL/min/100 g; P = .003). CONCLUSIONS: MR imaging arterial spin-labeling is a valuable tool for the assessment of soft-tissue vascular anomaly hemodynamics and for the classification of major lesion subtypes.

13 January 2020 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
BDBenoît Dumont
Benoît Dumont
BFBrice Fresneau
Brice Fresneau
LCLine Claude
Line Claude
ADAnne Sophie DEFACHELLES
Anne Sophie DEFACHELLES
VCVincent Couloigner
Vincent Couloigner
DODaniel Orbach
Daniel Orbach

3 November 2019 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
SKSonia Khirani
Sonia Khirani
AAAlessandro Amaddeo
Alessandro Amaddeo
GBGeneviève Baujat
Geneviève Baujat
CMCaroline Michot
Caroline Michot
VCVincent Couloigner
Vincent Couloigner
BFBrigitte Fauroux
Brigitte Fauroux